Use of the EIE-Recombinant-Chagas-Biomanguinhos kit to monitor cure of human Chagas' disease

Journal of Clinical Laboratory Analysis

Volumn 16, Issue 3, 2002, Pages 132-136

  Silva, Edimilson D ^c   Pereira, Valéria R A ^a   Gomes, Juliana A S ^a   Lorena, Virgínia Maria B ^a   Cançado, Joaquim R ^b   Ferreira, Antonio G P ^c   Krieger, Marco Aurélio ^a,d   Goldenberg, Samuel ^a,d   Correa Oliveira, Rodrigo ^a   Gomes, Yara M ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c Instituto de Technologia em Imunobiologicos   (Brazil)

^d Instituto de Biologia Molecular do Parana   (Brazil)

Author keywords

Chagas' disease; ELISA; Recombinant antigens; Serologic diagnostic follow up; Trypanosoma cruzi

Indexed keywords

BENZNIDAZOLE; NIFURTIMOX;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CHAGAS DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DRUG EFFICACY; HUMAN; MICROBIOLOGICAL EXAMINATION; PATIENT MONITORING; SERODIAGNOSIS; TREATMENT OUTCOME;

ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BRAZIL; CHAGAS DISEASE; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOLLOW-UP STUDIES; HUMANS; REAGENT KITS, DIAGNOSTIC; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY;

TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 18344368425     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcla.10028     Document Type: Article

References (15)

1. Criteria of Chagas disease cure
2. Resistance against Trypanosoma cruzi associated to anti-living trypomastigotes antibodies
3. Lytic antibody titer as a means of assessing cure after treatment of Chagas disease: A 10 year follow up study
4. Use of Trypanosoma cruzi purified glycoprotein (GP57/51) or trypomastigote shed antigens to gauge cure in human Chagas' disease
5. Use of a 24-kilodalton Trypanosoma cruzi recombinant protein to monitor cure of human Chagas' disease
6. Flow cytometry, a new approach to detect anti-live trypomastigote antibodies and monitor the efficacy of specific treatment in human Chagas' disease
7. Serodiagnosis of chronic Chagas' disease by using EIE-Recombinant-Chagas-Biomanguinhos
8. Structure and expression of two Trypanosoma cruzi genes encoding antigenic proteins bearing repetitive epitopes
9. Use of recombinant antigens for the accurate immunodiagnosis of Chagas' disease
10. Immunological and clinical evaluation of chagasic patients subjected to chemotherapy during the acute phase of Trypanosoma cruzi infection
11. In situ indirect fluorescent antibody: A new specific test to detect ongoing chagasic infections
12. Binding of antibody and resistance to lysis of Trypanosoma cruzi
13. Experimental chemotherapy of Trypanosoma cruzi infection: Persistence of parasite antigens and positive serology in parasitologically cured mice